These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8301202)

  • 1. Triflavin, an antiplatelet peptide, inhibits tumor cell-extracellular matrix adhesion through an arginine-glycine-aspartic acid-dependent mechanism.
    Sheu JR; Lin CH; Huang TF
    J Lab Clin Med; 1994 Feb; 123(2):256-63. PubMed ID: 8301202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triflavin, an Arg-Gly-Asp-containing peptide, inhibits human cervical carcinoma (HeLa) cell-substratum adhesion through an RGD-dependent mechanism.
    Sheu JR; Lin CH; Peng HC; Huang TF
    Peptides; 1994; 15(8):1391-8. PubMed ID: 7700842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triflavin, an Arg-Gly-Asp-containing peptide, inhibits the adhesion of tumor cells to matrix proteins via binding to multiple integrin receptors expressed on human hepatoma cells.
    Sheu JR; Lin CH; Peng HC; Huang TF
    Proc Soc Exp Biol Med; 1996 Oct; 213(1):71-9. PubMed ID: 8820826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of angiogenesis in vitro and in vivo: comparison of the relative activities of triflavin, an Arg-Gly-Asp-containing peptide and anti-alpha(v)beta3 integrin monoclonal antibody.
    Sheu JR; Yen MH; Kan YC; Hung WC; Chang PT; Luk HN
    Biochim Biophys Acta; 1997 Oct; 1336(3):445-54. PubMed ID: 9367172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triflavin inhibits platelet-induced vasoconstriction in de-endothelialized aorta.
    Sheu JR; Yen MH; Hung WC; Lee YM; Su CH; Huang TF
    Arterioscler Thromb Vasc Biol; 1997 Dec; 17(12):3461-8. PubMed ID: 9437193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triflavin, an Arg-Gly-Asp-containing antiplatelet peptide inhibits cell-substratum adhesion and melanoma cell-induced lung colonization.
    Sheu JR; Lin CH; Chung JL; Teng CM; Huang TF
    Jpn J Cancer Res; 1992 Aug; 83(8):885-93. PubMed ID: 1399825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triflavin, an Arg-Gly-Asp containing snake venom peptide, inhibits aggregation of human platelets induced by human hepatoma cell line.
    Sheu JR; Lin CH; Chung JL; Teng CM; Huang TF
    Thromb Res; 1992 Jun; 66(6):679-91. PubMed ID: 1519227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of murine melanoma cell-matrix adhesion and experimental metastasis by albolabrin, an RGD-containing peptide isolated from the venom of Trimeresurus albolabris.
    Soszka T; Knudsen KA; Beviglia L; Rossi C; Poggi A; Niewiarowski S
    Exp Cell Res; 1991 Sep; 196(1):6-12. PubMed ID: 1879472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of action of a potent antiplatelet peptide, triflavin from Trimeresurus flavoviridis snake venom.
    Huang TF; Sheu JR; Teng CM
    Thromb Haemost; 1991 Oct; 66(4):489-93. PubMed ID: 1665595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A potent antiplatelet peptide, triflavin, from Trimeresurus flavoviridis snake venom.
    Huang TF; Sheu JR; Teng CM
    Biochem J; 1991 Jul; 277 ( Pt 2)(Pt 2):351-7. PubMed ID: 1859363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triflavin, an antiplatelet Arg-Gly-Asp-containing peptide, is a specific antagonist of platelet membrane glycoprotein IIb-IIIa complex.
    Huang TF; Sheu JR; Teng CM; Chen SW; Liu CS
    J Biochem; 1991 Feb; 109(2):328-34. PubMed ID: 1864844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of in vitro tumor cell invasion by Arg-Gly-Asp-containing synthetic peptides.
    Gehlsen KR; Argraves WS; Pierschbacher MD; Ruoslahti E
    J Cell Biol; 1988 Mar; 106(3):925-30. PubMed ID: 2450101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiplatelet and antithrombotic effects of platelet glycoprotein IIb/IIIa (GPIIb/IIIa) inhibition by arginine-glycine-aspartic acid-serine (RGDS) and arginine-glycine-aspartic acid (RGD) (O-me)Y (SC-46749).
    Nicholson NS; Panzer-Knodle SG; Salyers AK; Taite BB; King LW; Miyano M; Gorczynski RJ; Williams MH; Zupec ME; Tjoeng FS
    J Pharmacol Exp Ther; 1991 Mar; 256(3):876-82. PubMed ID: 2005585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triflavin, an Arg-Gly-Asp-Containing Peptide, Inhibits B16-F10 Mouse Melanoma Cell Adhesion to Matrix Proteins via Direct Binding to Tumor Cells.
    Sheu JR; Huang TF
    J Biomed Sci; 1996; 3(5):359-364. PubMed ID: 11725118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disintegrin modulates rat glomerular mesangial cell behavior.
    Tsai TJ; Sheu JR; Chen YM; Yen CJ; Chen CF; Huang TF
    Nephron; 1995; 70(1):83-90. PubMed ID: 7617122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of RPE cell-mediated matrix adhesion and collagen gel contraction by crovidisin, a collagen-binding snake venom protein.
    Yang CH; Liu CZ; Huang TF; Yang CM; Lui KR; Chen MS; Hung PT
    Curr Eye Res; 1997 Nov; 16(11):1119-26. PubMed ID: 9395771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triflavin, an Arg-Gly-Asp-containing peptide, inhibits tumor cell-induced platelet aggregation.
    Sheu JR; Lin CH; Peng HC; Teng CM; Huang TF
    Jpn J Cancer Res; 1993 Oct; 84(10):1062-71. PubMed ID: 8226281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of the arginine-glycine-aspartic acid-directed cellular binding to type I collagen and rat mesenchymal cells in colorectal tumour differentiation.
    Del Buono R; Pignatelli M; Bodmer WF; Wright NA
    Differentiation; 1991 Mar; 46(2):97-103. PubMed ID: 2065868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthetic peptides inhibit adhesion of human tumor cells to extracellular matrix proteins.
    DeRoock IB; Pennington ME; Sroka TC; Lam KS; Bowden GT; Bair EL; Cress AE
    Cancer Res; 2001 Apr; 61(8):3308-13. PubMed ID: 11309285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ex-vivo and in-vivo antithrombotic effect of triflavin, an RGD-containing peptide.
    Sheu JR; Huang TF
    J Pharm Pharmacol; 1994 Jan; 46(1):58-62. PubMed ID: 8201528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.